The USDA recently issued its Interim Final Rule on U.S. hemp production. The FDA continues to delay action on its development of a formal regulatory regime for hemp-derived CBD. Jonathan Miller, the industry’s lead national lobbyist, shares his unique insight on the regulatory path forward for hemp and CBD.
Note: This webinar is part of a monthly series in which Frost Brown Todd attorneys focus on hemp-related topics and trends through the lens of various legal disciplines, from general regulatory to intellectual property, banking, and advertising law. For updates, visit www.hemplegallyspeaking.com.